Prostaglandin E2 inhibits formation of osteoclastlike cells in long‐term human marrow cultures but is not a mediator of the inhibitory effects of transforming growth factor β

C. Chenu, N. Kurihara, G. R. Mundy, G. David Roodman

Research output: Contribution to journalArticle

38 Scopus citations

Abstract

Prostaglandins are important local regulators of bone cell function and have been shown to have multiple effects on osteoclasts. Using a human bone marrow culture system in which multinucleated cells with osteoclast characteristics form, we have recently shown that TGF‐β is a potent inhibitor of osteoclastlike cell formation and appears to act at several stages of their development. Because it has been suggested that the effects of TGF‐β are mediated via a prostaglandin‐dependent mechanism, we determined the effects of prostaglandin E2 (PGE2) on total and osteoclastlike cell formation (detected by reactivity with the 23c6 monoclonal antibody, which identifies osteoclasts) in human marrow cultures and tested whether prostaglandin synthesis was responsible for the inhibitory effects of TGF‐β on multinucleated cell formation. These studies show that PGE2 is a potent inhibitor of both 23c6‐positive and negative multinucleated cell formation in human marrow cultures and that the effects of TGF‐β on multinucleated cell formation are not mediated by PGE2.

Original languageEnglish (US)
Pages (from-to)677-681
Number of pages5
JournalJournal of Bone and Mineral Research
Volume5
Issue number7
DOIs
StatePublished - Jul 1990

    Fingerprint

ASJC Scopus subject areas

  • Endocrinology, Diabetes and Metabolism
  • Orthopedics and Sports Medicine

Cite this